RP
Healthcare & Life Sciences
Retension Pharmaceuticals
United States
Retension Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.
series-b
series-b
Stage
2
Investors
About Retension Pharmaceuticals
Retension Pharmaceuticals is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Retension Pharmaceuticals is developing RTN-001, an orally administered selective phosphodiesterase type 5 inhibitor designed to improve vascular function and treat cardiovascular and vascular disorders.
Explore Retension Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.